Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2024-10 · 22 (8) · 563-576
DOI: 10.6004/jnccn.2024.0051 ↗Kurz gefasst
Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2024-10. Verfasst von Bijal Shah und 32 weiteren Autor:innen. Beteiligte Einrichtung: Moffitt Cancer Center. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) provide recommendations for management of ALL, with a focus on the classification of ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk assessment and stratification for risk-adapted therapy; treatment strategies for Philadelphia chromosome (Ph)-positive and Ph-negative ALL for both adolescent and young adult and adult patients; and supportive care considerations. This selection from the NCCN Guidelines for ALL focuses on treatment recommendations for adults with newly diagnosed Ph-negative ALL based on current evidence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Moffitt Cancer Center.
- University of Wisconsin Carbone Cancer Center.
- Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
- Fox Chase Cancer Center.
- City of Hope National Medical Center.
- University of Michigan Rogel Cancer Center.
Zitieren
APA
Shah, B., Mattison, R. J., Abboud, R., Abdelmessieh, P., Aldoss, I., Burke, P. W., DeAngelo, D. J., Dinner, S., Fathi, A. T., Gauthier, J., Haddadin, M., Jain, N., Jonas, B., Kirby, S., Liedtke, M., Litzow, M., Logan, A., Long, M., Luger, S., …, & Stehman, K. (2024). Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 22(8), 563-576. https://doi.org/10.6004/jnccn.2024.0051
Vancouver
Shah B, Mattison RJ, Abboud R, Abdelmessieh P, Aldoss I, Burke PW, et al. Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2024;22(8):563-576. doi:10.6004/jnccn.2024.0051
BibTeX
@article{Shah2024,
author = {Shah, Bijal and Mattison, Ryan J and Abboud, Ramzi and Abdelmessieh, Peter and Aldoss, Ibrahim and Burke, Patrick W and DeAngelo, Daniel J and Dinner, Shira and Fathi, Amir T and Gauthier, Jordan and Haddadin, Michael and Jain, Nitin and Jonas, Brian and Kirby, Suzanne and Liedtke, Michaela and Litzow, Mark and Logan, Aaron and Long, Meixiao and Luger, Selina and Mangan, James K and Massaro, Stephanie and May, William and Oluwole, Olalekan and Park, Jae and Przespolewski, Amanda and Rangaraju, Sravanti and Saygin, Caner and Schwartz, Marc and Shami, Paul and Tomlinson, Benjamin and Webster, Jonathan and Awotiwon, Ajibola and Stehman, Katie},
title = {Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {8},
pages = {563--576},
doi = {10.6004/jnccn.2024.0051}
}
EUVIMED